• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Parishin C通过与NAC结构域明显相互作用来调节α-突触核蛋白的淀粉样变转化。

Parishin C modulates the amyloid transformation of alpha-synuclein protein by apparently interacting with the NAC domain.

作者信息

Akhtar Almas, Singh Payal, Admane Nikita, Grover Abhinav

机构信息

School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.

School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.

出版信息

Biochim Biophys Acta Proteins Proteom. 2025 Jul 1;1873(4):141076. doi: 10.1016/j.bbapap.2025.141076. Epub 2025 May 7.

DOI:10.1016/j.bbapap.2025.141076
PMID:40345607
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder marked by the gradual deterioration of dopaminergic neurons in the brain and the presence of Lewy bodies (LB) within the remaining affected neurons, comprised of α-synuclein protein aggregates. Herein, we report a novel amyloid inhibitory potential of Parishin C on the amyloid transformation of the α-synuclein protein. Our studies involving computational screening and REMD simulation analysis revealed a strong interaction between Parishin C and the non-amyloid component (NAC domain), a known aggregation-prone region of the α-synuclein protein. Thioflavin T fluorescence assay demonstrated the inhibitory effect of Parishin C on amyloid transformation kinetics of α-synuclein, where even at the lowest concentration of Parishin C there was a 72 % reduction in the ThT maxima. ANS binding assay further revealed its ability to alter the surface hydrophobicity of the protein. An extensive evaluation using biophysical techniques indicated that Parishin C effectively prevented the formation of mature fibrillar species and promoted the formation of lower order aggregates with reduced cross-β-sheet signatures compared to the native α-synuclein aggregates. Collectively, our research highlights Parishin C's potential as a structural blueprint for developing new therapeutic compounds aimed at preventing the amyloidogenic transition in Parkinson's disease and related disorders.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是大脑中多巴胺能神经元逐渐退化,以及在剩余受影响神经元中存在路易小体(LB),路易小体由α-突触核蛋白聚集体组成。在此,我们报告了帕里辛C对α-突触核蛋白淀粉样变转化的一种新型淀粉样蛋白抑制潜力。我们涉及计算筛选和REMD模拟分析的研究表明,帕里辛C与非淀粉样成分(NAC结构域)之间存在强烈相互作用,NAC结构域是α-突触核蛋白中一个已知的易于聚集的区域。硫黄素T荧光测定法证明了帕里辛C对α-突触核蛋白淀粉样变转化动力学的抑制作用,即使在帕里辛C最低浓度下,硫黄素T最大值也降低了72%。ANS结合测定进一步揭示了其改变蛋白质表面疏水性的能力。使用生物物理技术进行的广泛评估表明,与天然α-突触核蛋白聚集体相比,帕里辛C有效地阻止了成熟纤维状物种的形成,并促进了具有减少的交叉β-折叠特征的低阶聚集体的形成。总的来说,我们的研究突出了帕里辛C作为开发旨在预防帕金森病及相关疾病中淀粉样变转变的新治疗化合物的结构蓝图的潜力。

相似文献

1
Parishin C modulates the amyloid transformation of alpha-synuclein protein by apparently interacting with the NAC domain.Parishin C通过与NAC结构域明显相互作用来调节α-突触核蛋白的淀粉样变转化。
Biochim Biophys Acta Proteins Proteom. 2025 Jul 1;1873(4):141076. doi: 10.1016/j.bbapap.2025.141076. Epub 2025 May 7.
2
The antiviral drug Ribavirin effectively modulates the amyloid transformation of α-Synuclein protein.抗病毒药物利巴韦林能有效调节α-突触核蛋白的淀粉样转化。
Comput Biol Chem. 2024 Oct;112:108155. doi: 10.1016/j.compbiolchem.2024.108155. Epub 2024 Jul 16.
3
Salvianolic acid B prevents the amyloid transformation of A53T mutant of α-synuclein.丹酚酸B可阻止α-突触核蛋白A53T突变体的淀粉样变。
Biophys Chem. 2025 Mar;318:107379. doi: 10.1016/j.bpc.2024.107379. Epub 2024 Dec 13.
4
Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.定义导致小鼠帕金森病表型的α-突触核蛋白种类。
J Biol Chem. 2019 Jul 5;294(27):10392-10406. doi: 10.1074/jbc.RA119.007743. Epub 2019 May 29.
5
Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.去甲肾上腺素与α-突触核蛋白纤颤过程中天然状态和中间状态的结合导致稳定且结构一致的细胞毒性物质的形成。
ACS Chem Neurosci. 2019 Jun 19;10(6):2741-2755. doi: 10.1021/acschemneuro.8b00650. Epub 2019 Apr 9.
6
Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.去泛素化酶 OTUB1 的淀粉样聚集物具有神经毒性,表明它们可能导致帕金森病的发生。
J Biol Chem. 2020 Mar 13;295(11):3466-3484. doi: 10.1074/jbc.RA119.009546. Epub 2020 Jan 31.
7
Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.在帕金森病中促炎 S100A9 与α-突触核蛋白的共聚集:体外和体内研究。
J Neuroinflammation. 2018 Jun 4;15(1):172. doi: 10.1186/s12974-018-1210-9.
8
Structural packing of the non-amyloid component core domain in α-synuclein plays a role in the stability of the fibrils.α-突触核蛋白中非淀粉样成分核心结构域的结构堆积在纤维的稳定性中起作用。
Biophys Chem. 2024 Jul;310:107239. doi: 10.1016/j.bpc.2024.107239. Epub 2024 Apr 16.
9
The small molecule ZPD-2 inhibits the aggregation and seeded polymerisation of C-terminally truncated α-Synuclein.小分子ZPD-2可抑制C端截短的α-突触核蛋白的聚集和种子聚合。
FEBS J. 2024 Dec;291(23):5290-5304. doi: 10.1111/febs.17310. Epub 2024 Oct 27.
10
Hydrophobic interaction of glycitein and α-synuclein inhibits the protein aggregation: A future perspective for modulation of Parkinson's disease.
Int J Biol Macromol. 2025 Mar;296:139436. doi: 10.1016/j.ijbiomac.2024.139436. Epub 2025 Jan 3.